Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | ALDH3A1 | P30838 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.39 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | VEGFA | P15692 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15230723 | 0.66 | CA1 (0.41) | CA1CA2L3MBTL1ALDH3A1POLB | |
| SCHEMBL15230721 | 0.66 | CA1 (0.41) | CA1CA2L3MBTL1ALDH3A1POLB | |
| SCHEMBL10854578 | 0.66 | MMP2 (0.42) | CA1CA2L3MBTL1POLBHTT | |
| SCHEMBL18951957 | 0.66 | CA1 (0.53) | CA1CA2L3MBTL1ALDH3A1POLB | |
| SCHEMBL25301888 | 0.64 | RAPGEF4 (0.54) | CA1CA2L3MBTL1ALDH3A1POLB | |
| SCHEMBL30081932 | 0.63 | L3MBTL1 (0.59) | CA1CA2L3MBTL1ALDH3A1POLB | |
| SCHEMBL1354366 | 0.63 | L3MBTL1 (0.59) | CA1CA2L3MBTL1ALDH3A1POLB | |
| SCHEMBL1365792 | 0.63 | RAPGEF4 (0.61) | CA1CA2L3MBTL1ALDH3A1POLB | |
| SCHEMBL33525683 | 0.62 | L3MBTL1 (0.40) | CA1CA2L3MBTL1ALDH3A1POLB | |
| SCHEMBL30977560 | 0.62 | L3MBTL1 (0.45) | CA1CA2L3MBTL1ALDH3A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190169186-A1 | CRYSTALLINE SOLID FORMS OF A BET INHIBITOR | INCYTE CORPORATION | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169186-A1 | CRYSTALLINE SOLID FORMS OF A BET INHIBITOR | BRD1, BRD3, BRD2 | CA1 3670/4885CA2 4071/4885L3MBTL1 708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.